Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.
about
Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis.Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisSynthetic investigational new drugs for the treatment of tuberculosis.
P2860
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Delamanid when other anti-tube ...... to resistance or tolerability.
@en
type
label
Delamanid when other anti-tube ...... to resistance or tolerability.
@en
prefLabel
Delamanid when other anti-tube ...... to resistance or tolerability.
@en
P2860
P1476
Delamanid when other anti-tube ...... to resistance or tolerability
@en
P2093
Won-Jung Koh
Yong-Soo Kwon
P2860
P304
P356
10.1517/14656566.2015.973853
P407
P577
2014-10-18T00:00:00Z